Viewing Study NCT04573920


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-02-25 @ 8:59 PM
Study NCT ID: NCT04573920
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-11
First Post: 2020-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Atrasentan in Patients With Proteinuric Glomerular Diseases
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module